» Articles » PMID: 1303173

Both Mutations in G6PD A- Are Necessary to Produce the G6PD Deficient Phenotype

Overview
Journal Hum Mol Genet
Date 1992 Jun 1
PMID 1303173
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The high prevalence of glucose 6-phosphate dehydrogenase (G6PD) deficiency in African populations is due almost entirely to the enzyme variant A-, which differs from the wild-type G6PD B by two amino acid replacements, 68 Val-->Met and 126 Asn-->Asp. The non-deficient polymorphic variant G6PD A contains only the mutation 126 Asn-->Asp. The frequencies of the G6PD A and of the G6PD A- genes in parts of Africa are both about 0.2. The 68 Val-->Met mutation has not been found in a B background. This could be because the 68 Val-->Met mutation happened to arise in an A gene in the first instance, or because the 68 Val-->Met mutation alone is not sufficient to cause G6PD deficiency. We have approached this question by producing G6PD B, A, A-, and G6PD 68 Val-->Met in a bacterial expression system and analysing their biochemical properties. With each single mutation we found a slight decrease in both the specific activity and the yield of enzyme when compared to G6PD B. When both mutations were introduced together, there was a roughly additive effect on specific activity, but a much more drastic effect on enzyme yield (4% of normal). This synergistic effect was also demonstrated on thermal stability, especially at low NADP concentrations. Comparable results were produced when the replacement 119 Gln-->Glu was studied instead of 126 Asn-->Asp. We infer that the coexistence of the two mutations is responsible for enzyme deficiency in G6PD A- because they act synergistically in causing instability of the enzyme.

Citing Articles

Computational analysis of dimer G6PD structure to elucidate pathogenicity of G6PD variants.

Chandran S, Louis N, Amran S, Ab Latif N, Hamza M, Alonazi M Biomedicine (Taipei). 2024; 14(1):47-59.

PMID: 38533298 PMC: 10962564. DOI: 10.37796/2211-8039.1431.


Hemoglobinopathies, merozoite surface protein-2 gene polymorphisms, and acquisition of Epstein Barr virus among infants in Western Kenya.

Olewe P, Awandu S, Munde E, Anyona S, Raballah E, Amolo A BMC Cancer. 2023; 23(1):566.

PMID: 37340364 PMC: 10280846. DOI: 10.1186/s12885-023-11063-2.


Molecular dynamics of G6PD variants from sub-Saharan Africa.

da Rocha J, Othman H, Hazelhurst S Biochem Biophys Rep. 2022; 30:101236.

PMID: 35313643 PMC: 8933681. DOI: 10.1016/j.bbrep.2022.101236.


Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India.

Rajkhowa P, Nath C, Dutta A, Misurya I, Sharma N, Barman B Cureus. 2020; 12(11):e11463.

PMID: 33214970 PMC: 7671175. DOI: 10.7759/cureus.11463.


Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.

Zuchelkowski B, Wang L, Gingras S, Xu Q, Yang M, Triulzi D PLoS One. 2020; 15(10):e0240266.

PMID: 33007039 PMC: 7531777. DOI: 10.1371/journal.pone.0240266.